We are live on
!
Find out more
CA
Cornerstone Advisors Portfolio holdings
AUM
$3.04B
Turnover
28.46%
1-Year Est. Return
36.62%
This Fund
S&P 500
This Quarter
Est. Return
-12.49%
1 Year Est. Return
+36.62%
3 Year Est. Return
+108.19%
5 Year Est. Return
+137.76%
10 Year Est. Return
–
AUM
$1.14B
AUM Growth
-$248M
(-18%)
Cap. Flow
-$66.5M
Cap. Flow
% of AUM
-5.84%
Top 10 Holdings %
Top 10 Hldgs %
25.87%
Holding
266
New
45
Increased
38
Reduced
60
Closed
43
Avg Time Held
1.3
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$10.4M |
| 2 |
Merck
MRK
|
+$10.3M |
| 3 |
Procter & Gamble
PG
|
+$7.15M |
| 4 |
Cisco
CSCO
|
+$6.86M |
| 5 |
Nike
NKE
|
+$4.86M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$13.6M |
| 2 |
Meta Platforms (Facebook)
META
|
+$10.4M |
| 3 |
Oracle
ORCL
|
+$10.2M |
| 4 |
Altria Group
MO
|
+$9.05M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 18.74% |
| 2 | Technology | 14.48% |
| 3 | Healthcare | 14% |
| 4 | Financials | 13.77% |
| 5 | Communication Services | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Elevance Health
ELV
$92.9B
| $6.04M | 0.53% |
23,000
| – | – |
2018 Q3
1 quarter
|
|
52
Cigna
CI
$79B
| $5.8M | 0.51% |
30,519
+8,519
| +39% | +$1.78M |
2013 Q2
22 quarters
|
|
53
Cohen & Steers REIT and Preferred and Income Fund
RNP
$885M
| $5.74M | 0.5% |
322,610
+185,182
| +135% | +$3.38M |
2017 Q4
4 quarters
|
|
54
Goldman Sachs
GS
$260B
| $5.68M | 0.5% |
34,000
| – | – |
2016 Q4
8 quarters
|
|
55
DuPont de Nemours
DD
$17.8B
| $5.57M | 0.49% |
41,113
| – | – |
2013 Q2
22 quarters
|
|
56
CME Group
CME
$104B
| $5.32M | 0.47% |
28,300
+20,300
| +254% | +$3.75M |
2018 Q3
1 quarter
|
|
|
MGU
57
DELISTED
Macquarie Global Infrastructure Total Return Fund, Inc.
MGU
| $5.29M | 0.46% |
281,101
-12,969
| -4% | -$260K |
2015 Q2
14 quarters
|
|
58
TJX Companies
TJX
$159B
| $5.19M | 0.46% |
116,000
| – | – |
2017 Q1
7 quarters
|
|
59
CVS Health
CVS
$118B
| $5.12M | 0.45% |
78,081
-14,919
| -16% | -$1.11M |
2017 Q1
7 quarters
|
|
60
Amgen
AMGN
$235B
| $5.06M | 0.44% |
26,000
-20,000
| -43% | -$3.9M |
2017 Q1
7 quarters
|
|
61
CSX Corp
CSX
$90.2B
| $5.03M | 0.44% |
242,700
| – | – |
2017 Q2
6 quarters
|
|
62
Lowe's Companies
LOW
$110B
| $4.99M | 0.44% |
54,000
| – | – |
2017 Q1
7 quarters
|
|
63
Thermo Fisher Scientific
TMO
$258B
| $4.92M | 0.43% |
22,000
| – | – |
2013 Q3
21 quarters
|
|
|
64
Nike
NKE
$55.2B
| $4.82M | 0.42% |
+65,000
| New | +$4.86M |
2018 Q4
0 quarters
|
|
65
Deere & Co
DE
$175B
| $4.77M | 0.42% |
32,000
| – | – |
2016 Q3
9 quarters
|
|
66
NextEra Energy
NEE
$165B
| $4.69M | 0.41% |
108,000
| – | – |
2015 Q1
15 quarters
|
|
67
Estee Lauder
EL
$38.8B
| $4.68M | 0.41% |
36,000
| – | – |
2017 Q2
6 quarters
|
|
68
Accenture
ACN
$138B
| $4.65M | 0.41% |
33,000
| – | – |
2018 Q1
3 quarters
|
|
69
Honeywell
HON
$66.7B
| $4.62M | 0.41% |
37,135
-1,610
| -4% | -$220K |
2017 Q2
6 quarters
|
|
70
TRI-Continental Corp
TY
$1.84B
| $4.62M | 0.41% |
196,353
-285,609
| -59% | -$7.35M |
2016 Q2
10 quarters
|
|
71
American Express
AXP
$212B
| $4.58M | 0.4% |
48,000
| – | – |
2017 Q4
4 quarters
|
|
72
Simon Property Group
SPG
$65.8B
| $4.52M | 0.4% |
+26,900
| New | +$4.81M |
2018 Q4
0 quarters
|
|
73
Norfolk Southern
NSC
$73B
| $4.34M | 0.38% |
29,000
| – | – |
2017 Q2
6 quarters
|
|
74
Exelon
EXC
$43.8B
| $4.19M | 0.37% |
130,386
| – | – |
2018 Q3
1 quarter
|
|
75
Intuit
INTU
$88.2B
| $4.13M | 0.36% |
21,000
+12,000
| +133% | +$2.5M |
2017 Q3
5 quarters
|
|
Similar funds
GFA
SL
JFGIW
Cornerstone Advisors's Q4 2018 Portfolio in Review
As of Q4 2018, Cornerstone Advisors held 266 positions worth $1.14B, down 18% from $1.39B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Cornerstone Advisors withdrew a net $66.5M in Q4 2018, closing 43 positions and reducing 60 holdings. Its most notable exit was AbbVie, an estimated $13.6M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 19% of assets, down from 19% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Cornerstone Advisors opened a new position in Merck worth $10.6M.
- Cornerstone Advisors's largest Q4 2018 buy was Merck: 145,462 shares worth $10.6M.
- Cornerstone Advisors added most to ExxonMobil in Q4 2018, an estimated $10.4M increase.
- Cornerstone Advisors's biggest Q4 2018 reduction was Meta Platforms (Facebook), cutting an estimated $10.4M.
- Cornerstone Advisors fully exited AbbVie in Q4 2018, selling an estimated $13.6M.
- Cornerstone Advisors's ten largest holdings make up 26% of its $1.14B portfolio in Q4 2018.
- Cornerstone Advisors opened 45 new positions and closed 43 in Q4 2018.
- Cornerstone Advisors's portfolio value fell 18% quarter-over-quarter to $1.14B.
Based on Cornerstone Advisors's 13F filing for Q4 2018, filed 12 Feb 2019.